[1]Chen X, Wang T, Song L, et al. Activation of multiple Toll-like receptors serves different roles in sepsis-induced acute lung injury[J]. Exp Ther Med, 2019, 18(1): 443-450.
[2]Zhou J, Fu Y, Liu K, et al. miR-206 regulates alveolar type II epithelial cell Cx43 expression in sepsis-induced acute lung injury[J]. Exp Ther Med, 2019, 18(1): 296-304.
[3]Shashaty MGS, Reilly JP, Faust HE, et al. Plasma receptor interacting protein kinase-3 levels are associated with acute respiratory distress syndrome in sepsis and trauma: a cohort study[J]. Crit Care, 2019, 23(1): 235.
[4]Shen Y, Song J, Wang Y, et al. M2 macrophages promote pulmonary endothelial cells regeneration in sepsis-induced acute lung injury[J]. Ann Transl Med, 2019, 7(7): 142.
[5]刘萌萌, 李彦文, 周庆彪, 等. 氯气吸入致大鼠肺血管内皮细胞的线粒体损伤及红景天苷的干预作用[J]. 癌变·畸变·突变, 2018, 30(1): 31-36,41.
[6]罗葵, 曹丽歌, 高丽芳, 等. 红景天片提高缺氧耐受力的功能研究[J]. 食品研究与开发, 2016, 37(17): 158-160.
[7]韩悦, 史佳, 吴丽丽, 等. PI3K/Akt/Nrf2信号通路在电针刺减轻兔内毒素休克诱发急性肺损伤中的作用[J]. 中国中西医结合外科杂志, 2018, 24(2): 197-202.
[8]王平, 吴惠玲, 朱娱, 等. 水通道蛋白亚型3在脓毒症肺血管通透性中的作用及SS-31对其的影响[J]. 第三军医大学学报, 2017, 39(2): 111-115.
[9]Li L, Shu MQ, Chen J. CYLD deficiency exacerbates lipopolysaccharide (LPS)-induced pyroptosis in astrocytes of mice with sepsis[J]. Biochem Biophys Res Commun, 2019, 514(4): 1066-1073.
[10]Cai X, Chen Y, Xie X, et al. Astaxanthin prevents against lipopolysaccharide-induced acute lung injury and sepsis via inhibiting activation of MAPK/NF-κB[J]. Am J Transl Res, 2019, 11(3): 1884-1894.
[11]Wang J, Fan SM, Zhang J. Epigallocatechin-3-gallate ameliorates lipopolysaccharide- induced acute lung injury by suppression of TLR4/NF-κB signaling activation [J]. Braz J Med Biol Res, 2019, 52(7): e8092.
[12]Krebs J, Hillenbrand A, Tsagogiorgas C, et al. Intravenous delivery of granulocyte-macrophage colony stimulating factor impairs survival in lipopolysaccharide- induced sepsis [J]. PLoS One, 2019, 14(6): e0218602.
[13]王晓鹏, 陈腾飞, 罗丹, 等. 基于不同辨证体系的脓毒症休克中医病机探析[J]. 中国中医急症, 2018, 27(1): 101-104.
[14]张新茹, 于玲, 王冬雪, 等. 红景天苷通过micro RNA-370改善2型糖尿病小鼠糖代谢的作用机制[J]. 医药导报, 2018, 37(3): 279-284.
[15]Lan KC, Chao SC, Wu HY, et al. Salidroside ameliorates sepsis-induced acute lung injury and mortality via downregulating NF-κB and HMGB1 pathways through the upregulation of SIRT1[J]. Sci Rep, 2017, 7(1): 12026.
[16]Huang LY, Yen IC, Tsai WC, et al. Rhodiola crenulata attenuates high glucose induced endothelial dysfunction in human umbilical vein endothelial cells [J]. Am J Chin Med, 2017, 45(6): 1201-1216.
[17]Blet A, Deniau B, Geven C, et al. Adrecizumab, a non-neutralizing anti-adrenomedullin antibody, improves haemodynamics and attenuates myocardial oxidative stress in septic rats[J]. Inten Care Med Exp, 2019, 7(1):25.
[18]Liu Q, Xie J, Yang Y. Advances in the regulation mechanism of cholinergic anti-inflammatory pathway on sepsis [J]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2019, 31(6): 781-784.
[19]Molinaro R, Anna Pastò, Corbo C, et al. Macrophage-derived nanovesicles exert intrinsic anti-inflammatory properties and prolong survival in sepsis through a direct interaction with macrophages [J]. Nanoscale, 2019, 11(28): 13576-13586.
[20]Zusso M, Lunardi V, Franceschini D, et al. Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-κB pathway [J]. J Neuroinflammation, 2019, 16(1): 148.
[21]Ding Y, Feng Q, Chen J, et al. TLR4/NF-κB signaling pathway gene single nucleotide polymorphisms alter gene expression levels and affect ARDS occurrence and prognosis outcomes [J]. Medicine (Baltimore), 2019, 98(26): e16029.
[22]Zhao C, Wang Y, Yuan X, et al. Berberine inhibits lipopolysaccharide-induced expression of inflammatory cytokines by suppressing TLR4-mediated NF-κB and MAPK signaling pathways in rumen epithelial cells of Holstein calves [J]. J Dairy Res, 2019, 86(2): 171-176.
[23]Guo NF, Cao YJ, Chen X, et al. Lixisenatide protects doxorubicin-induced renal fibrosis by activating NF-κB/TNF-α and TGF-β/Smad pathways [J]. Eur Rev Med Pharmacol Sci, 2019, 23(9): 4017-4026.
[24]Zhou CN, Yao W, Gong YN, et al. 22-oxacalcitriol protects myocardial ischemia-reperfusion injury by suppressing NF-κB/TNF-α pathway [J]. Eur Rev Med Pharmacol Sci, 2019, 23(12): 5495-5502. |